PharmaciaPub Date : 2023-11-07DOI: 10.3897/pharmacia.70.e107406
Fathoni Ega Mulyana, Stephanus Satria Wira Waskitha, Deni Pranowo, Melati Khairuddean, Tutik Dwi Wahyumingsih
{"title":"Synthesis of chalcone derivatives with methoxybenzene and pyridine moieties as potential antimalarial agents","authors":"Fathoni Ega Mulyana, Stephanus Satria Wira Waskitha, Deni Pranowo, Melati Khairuddean, Tutik Dwi Wahyumingsih","doi":"10.3897/pharmacia.70.e107406","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e107406","url":null,"abstract":"Malaria remains an endemic disease in tropical regions, urgently needed the search for effective antimalarial agents due to resistance against existing drugs. This study investigated the potential antimalarial activity of pyridine-based chalcone derivatives against P. falciparum 3D7 and FCR3 strains. The chalcones were synthesized through a one-pot method using various pyridine carbaldehyde, resulting in yields ranging from 53.74 to 86.37%, and all products were characterized using FTIR, GC-MS, and NMR spectroscopies. Among the six chalcones tested, chalcone A [1-(2-methoxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one] displayed the highest antimalarial activity with IC 50 values of 0.48 and 0.31 μg/mL against P. falciparum 3D7 and FCR3 strains, respectively, and a resistance index of 0.65. Molecular docking studies highlighted the interaction of the carbonyl group of all chalcones with Asn108 amino acid residue in the P f DHFR-TS active site via hydrogen bonding, demonstrating their potential as the antimalarial agent. Notably, the positioning of methoxy and pyridine substituents significantly influenced the antimalarial activity of the chalcones.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135475176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-11-02DOI: 10.3897/pharmacia.70.e108922
Hendy Suhendy, Irda Fidrianny, Muhamad Insanu
{"title":"Phytochemical compounds and pharmacological activities of Ipomoea batatas L.: An updated review","authors":"Hendy Suhendy, Irda Fidrianny, Muhamad Insanu","doi":"10.3897/pharmacia.70.e108922","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e108922","url":null,"abstract":"This article provides an overview of Ipomoea batatas L., the Ipomoea genus. The review covers traditional uses, nutritional value, phytochemical compounds, pharmacological activities, and toxicity studies. Data were collected from scientific databases and search engines. Sweet potatoes are used in various countries for traditional uses such as dietary fiber sources, treating allergies, and providing energy in diabetes mellitus treatment. The primary phytochemical compounds in Ipomoea batatas are phenolic compounds, flavonoids, anthocyanins, and carotenoids. Sweet potato contains several nutritional constituents: vitamin C, protein, fiber, carbohydrates, β-carotene, and minerals. Sweet potato exhibits various pharmacological activities, such as antioxidant, aphrodisiac, anticancer, and anti-inflammatory. The types of phytochemical compounds in each part of the plant are different. Each pharmacological activity and mechanism of action depends on the phytochemical compounds, part and variety of the plant, and extraction solvent. However, further study is required to investigate the chronic toxicity of Ipomoea batatas .","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135932966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-11-01DOI: 10.3897/pharmacia.70.e110191
Asmaa Abdelaziz Mohamed, Noor Zuhair Kbah, Osama N. Wennas
{"title":"Poly (lactic-co-glycolic acid) nanoparticles for drug delivery of rupatadine fumarate: development and evaluation","authors":"Asmaa Abdelaziz Mohamed, Noor Zuhair Kbah, Osama N. Wennas","doi":"10.3897/pharmacia.70.e110191","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e110191","url":null,"abstract":"This study aimed to consolidate rupatadine fumarate (RF) into nanoparticles to control its release. Ten RF nanoparticles were developed by nanoprecipitation using poly (lactic-co-glycolic acid) (PLGA) , polyvinyl alcohol (PVA), and Poloxamer 407 (Kolliphor P 407) in different percentages. A valid reverse-phase HPLC method was developed to assess RF in the formulated nanoparticles. The RF nanoparticles were tested chemically and morphologically. RF nanoparticles containing PLGA and PVA and Kolliphor P 407 have zeta potentials ranging from -24.4 mV±0.24 to -26.7 mV±0.05, higher than other formulations, and their release profiles were optimised. The formula (RPX3) had the best zeta potential (-26.7 mV±0.05), released about 86% of RF after 8 h and extended for 24 h. In summary, the formulation (RPX3), including 2:10:3:1.5 ratios of the drug PLGA: PVA: Kolliphor P 407 was the optimised RF-loaded nanoparticles formulation.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135320500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Separation and analysis of triazole antifungal in biological matrices by liquid chromatography: a review","authors":"Untung Gunawan, Slamet Ibrahim, Atthar Luqman Ivansyah, Sophi Damayanti","doi":"10.3897/pharmacia.70.e111511","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e111511","url":null,"abstract":"Invasive fungal infections cause serious illness and death worldwide. Long-term therapeutic and preventative use of antifungal drugs in high-risk patients has caused resistance. Triazole antifungals are widely used to prevent and treat fungal infections, and therapeutic drug monitoring has been suggested to improve outcomes, reduce toxicity, and prevent drug resistance. Common methods used for monitoring triazole antifungal drugs in biological matrices such as blood, serum, and plasma include bioassay and instrumentation methods, especially liquid chromatography. Sample preparation is needed to remove interference from liquid chromatography for reliable results. This paper evaluates the use of liquid chromatography to analyze triazole antifungal agents. We provided various chromatographic techniques combined with different detector types to analyze triazole antifungal drugs in biological matrices. We also compared chromatography systems with different sample preparation methods in order to select the most suitable analytical method for bioanalysis.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135321700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-30DOI: 10.3897/pharmacia.70.e113462
Petya Milushewa, Stilyana Blagova, Presiyana Stefanova, Konstantin Tachkov, Guenka Petrova
{"title":"Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List","authors":"Petya Milushewa, Stilyana Blagova, Presiyana Stefanova, Konstantin Tachkov, Guenka Petrova","doi":"10.3897/pharmacia.70.e113462","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e113462","url":null,"abstract":"Objective : The primary aim of this study was to evaluate, for the first time, the use of the EU-7 PIM List in identifying potentially inappropriate medications among older patients. Researchers have firmly established the connection between drug-related problems, which include increased morbidity and mortality rates and the heightened utilization of healthcare services. While previous studies have focused on methodologies for identifying potentially inappropriate medications in Bulgaria, further research is warranted to explore the applicability of the widely recognized EU(7)- PIM List. Materials and methods : A prospective review was conducted on patient prescriptions aligned with the National Health and Insurance Fund, explicitly focusing on patients aged over 65 years from a single pharmacy in Veliko Turnovo City, Bulgaria. The review spanned from November 2022 to April 2023. The prescriptions analyzed in this study exclusively comprised medications covered by the insurance fund. The pharmacy manager provided patient prescription data in a coded form, which included information on the patients’ age, corresponding medications, and accompanying ICD codes. Results : The study analyzed a sample of 255 patients. Healthcare providers prescribed 2,623 medications, and 61.96% of the patients had polypharmacy, taking more than five medications daily. Among the study population, 67% with polypharmacy had at least one PIM based on the EU (7)-PIM List criteria. In total, 173 potentially inappropriate medications (PIMs) were identified. The main PIMs were categorized into four groups: alimentary tract and metabolism, blood and blood-forming organs, cardiovascular system (CVS), and nervous system. Most PIMs (75.72%) were in the ATC cardiovascular system. Within the CVS category, 11 PIMs were associated with digoxin intake and 11 with antiarrhythmics such as propafenone, flecainide, and amiodarone. In addition, trimetazidine was linked to 9 PIMs, and centrally acting antiadrenergic agents had 22 PIMs, with moxonidine being the most prevalent (n=16). Peripherally acting agents were linked to 22 PIMs, primarily doxazosin. The study identified 24 PIMs related to diuretics, specifically spironolactone, and 18 PIMs related to selective calcium channel blockers such as verapamil. The antithrombotic agent category had the highest share, with 30 identified PIMs, including acenocoumarol, dabigatran, rivaroxaban, and apixaban. Furthermore, the examination of ICD codes confirmed that most PIMs occurred within CVS, with patients having ICD I11.0 and ICD I11.9 being associated with 40 and 47 PIMs, respectively. Conclusion : This study highlights many PIMs among patients with cardiovascular diseases. Using the EU (7)-PIM List as a pilot study demonstrates its effectiveness in managing adult patients’ conditions. Given the significant role of PIMs in deprescribing strategies for older patients with polypharmacy, there is a need for prescribers, educators, and drug regulat","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136068368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-27DOI: 10.3897/pharmacia.70.e114071
Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, Valentina Boyanova Petkova
{"title":"Prevention of cardiovascular diseases","authors":"Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, Valentina Boyanova Petkova","doi":"10.3897/pharmacia.70.e114071","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e114071","url":null,"abstract":"Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for patients with established cardiovascular disease and those at high risk include smoking cessation, healthy eating, physical activity, and lowering body mass index. There are various methods that are part of health promotion to reduce CVD risks. These methods include motivational interviewing, non-pharmacological means, the use of certain medications for CVD prevention, as well as physical activity. Strategies for effective primary prevention refer to engaging the patient to change their lifestyle and identifying risk factors, while secondary prevention is aimed at activities to detect the disease early and to slow down its progression. It is necessary to create a strategy for timely preventive actions with a view to preventing the negative influence of risk factors and improving people‘s heart health.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136236032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-25DOI: 10.3897/pharmacia.70.e111279
Olha Khvorost, Yevheniia Zudova, Liliia Budniak, Liudmyla Slobodianiuk, Hanna Kramar, Olha Palamarchuk, Anna Ocheretniuk
{"title":"Analysis of carboxylic acids of Astragalus dasyanthus Pall. herb","authors":"Olha Khvorost, Yevheniia Zudova, Liliia Budniak, Liudmyla Slobodianiuk, Hanna Kramar, Olha Palamarchuk, Anna Ocheretniuk","doi":"10.3897/pharmacia.70.e111279","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e111279","url":null,"abstract":"One of the fundamental issues in modern pharmacy is the expansion of the range of medications based on plant-derived raw materials with specific targeted effects. An example of such a plant is the woolly-flowered milkvetch ( Astragalus dasyanthus Pall.). This perennial herbaceous medicinal plant belongs to the Fabaceae family and is listed in the Red Book of Europe. Astragalus dasyanthus Pall. is cultivated for pharmaceutical purposes. The herb of a plant exhibits sedative, cardiotonic, hypotensive, and diuretic effects, as well as hepatoprotective and antioxidant properties. The herb of Astragalus dasyanthus Pall. contains polysaccharides (arabinose, bassorin), flavonoids (quercetin, kaempferol), glycyrrhizin, starch, and triterpenoid saponins, which contribute to the broad spectrum of the plant’s pharmacological activity. Continuing the investigation of this plant, it is advisable to study the qualitative and quantitative composition of organic and fatty acids. By the HPLC method, the following organic acids were identified and determined quantitative content: tartaric (8.68 mg/g), citric (7.69 mg/g), oxalic (6.90 mg/g), succinic (5.01 mg/g), isocitric (1.30 mg/g), and malic (0.49 mg/g). The saturated and unsaturated fatty acids were determined by the GC/MS method. The Astragalus dasyanthus Pall. herb contained seven fatty acids. High concentrations of fatty acids such as pentadecanoic acid (4.16 mg/g), linoleic acid (1.73 mg/g), and stearic acid (1.14 mg/g) predominate in woolly-flowered milkvetch. The character of many processes in which these organic and fatty acids take part may be associated with the medicinal properties of this plant pursuant to its use in medicine and, therefore, may contribute to the insight into its therapeutic properties.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135217720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-25DOI: 10.3897/pharmacia.70.e103566
Embun Suci Nasution, Hari Ronaldo Tanjung, Inggianti Putri
{"title":"Evaluation of antibiotics using ATC/DDD and DU 90% methods on ICU patients at Universitas Sumatera Utara Hospital","authors":"Embun Suci Nasution, Hari Ronaldo Tanjung, Inggianti Putri","doi":"10.3897/pharmacia.70.e103566","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e103566","url":null,"abstract":"Background : Evaluation of the use of antibiotics is the control of antimicrobial resistance. The ATC/DDD method was recommended to evaluate drug use quantitatively which can be used to compare the quantity of antibiotic use between hospitals and between countries. This research was a descriptive study with retrospective data collection cross-sectional. This research was conducted at the ICU of Universitas Sumatera Utara hospital in August-November 2022 from medical record data for the period January-December 2021 which included patient demographics, patient diagnoses, antibiotic dosage forms, routes of administration, types of antibiotics, dosage, duration of antibiotics use, and duration of treatment. Methods : Evaluation of antibiotic doses using the ATC/DDD method. The results of the study from 57 medical records that met the inclusion criteria showed that the ICU patients who used the most antibiotics were male (59.7%), the age group was >56 years (56.14%), patient diagnoses with COVID-19 (33.33%), and the dosage form was injection with the intravenous route of administration. The most frequently used antibiotics were levofloxacin (48.54%) 45.61 DDD/100 patient-days and ceftriaxone (30.06%) 28.25 DDD/100 patient-days, and the average value of Length of Stay (LOS) is 5.4 ±3.98 days with a total DDD/100 patient-days value of 93.96 (reference value of 51–67 DDD/100 patient-days). DU 90% segment namely levofloxacin (48.69%), ceftriaxone (30.16%) and meropenem (12.82%). The results of the study concluded that the use of antibiotics in ICU patients at Universitas Sumatera Utara Hospital showed a high DDD/100 patient-days rate. Therefore, it is necessary for hospital to continuously monitor and evaluated the rational use of antibiotics to prevent resistance of antibiotics.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135111515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-25DOI: 10.3897/pharmacia.70.e113883
Konstantin Kostov, Vesselin Marinov, Stefka Ivanova, Mariya Chaneva, Petar Atanasov, Venceslava Atanasova
{"title":"Laparoscopic IPOMPLUS repair-current outcomes and complications","authors":"Konstantin Kostov, Vesselin Marinov, Stefka Ivanova, Mariya Chaneva, Petar Atanasov, Venceslava Atanasova","doi":"10.3897/pharmacia.70.e113883","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e113883","url":null,"abstract":"Purpose : The study aims to assess the current outcomes and complications of laparoscopic ventral hernia repair using intraperitoneal onlay mesh with defect closure (IPOM PLUS) technique by use of dual-sided synthetic mesh. Material and methods : Retrospectively clinical data for 27 patients with umbilical, paraumbilical, incisional, ventral, and primary hernia, operated in the Department of General, Visceral and Emergency Surgery “Pirogov” from 01.06.2022 to 01.06. 2022 was analyzed. The diagnosis was based on history, physical examination(mainly), ultrasound, and CT. Of the hospitalized, women were 16 (59.26%) men 11 (40.74%). Results : Of the selected group, 13 patients had umbilical defects, 3 with an epigastric hernia, 7 with a paraumbilical hernia, and 4 with incisional defects. Adhesiolysis was needed in 18 cases, while others were performed straight with hernia closure. The operating time varied between 49 and 127 minutes (average 57.4 minutes). The hospital stay ranged from 1 day to 4 days (average 1.7 days). We had noticed complications in three of the cases (11.11%). Conclusion : IPOM PLUS repair is safe, practicable, and advantageous over a standard IPOM or open repair as reported in the literature. Accordingly, we prefer this approach with the closure of the fascial defect first while repairing ventral abdominal wall hernias.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135216008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PharmaciaPub Date : 2023-10-24DOI: 10.3897/pharmacia.70.e112645
Ema Pristi Yunita, Rayfika Nokha Kusuma Wardani, Bambang Sidharta
{"title":"Correlation between knowledge level, side effect severity, family support, and antiretroviral therapy adherence in HIV/AIDS patients in Greater Malang, East Java, Indonesia","authors":"Ema Pristi Yunita, Rayfika Nokha Kusuma Wardani, Bambang Sidharta","doi":"10.3897/pharmacia.70.e112645","DOIUrl":"https://doi.org/10.3897/pharmacia.70.e112645","url":null,"abstract":"Human Immunodeficiency Virus (HIV) is a virus that attacks and weakens the human immune system, leading to Acquired Immune Deficiency Syndrome (AIDS) symptoms. East Java is one of the provinces in Indonesia with a high HIV prevalence. Antiretroviral therapy (ART) is a critical approach to slow down the growth rate of HIV since no medicine has been found for HIV/AIDS patients. Therefore, high adherence to ART is necessary to reduce viral replication and prevent the development of resistance. This study aimed to investigate the correlation between knowledge level, side effect severity, family support, and ART adherence in HIV/AIDS patients. This observational analytic study with a cross-sectional design was conducted in September-October 2022 at the Netral Plus Indonesia Foundation and Malang Islamic Hospital. The study included 55 HIV/AIDS patients, and the Spearman correlation test was used to analyze the data. There was no significant relationship between knowledge level, side effects, and adherence to ART treatment (p = 0.959; p = 0.719). However, family support was found to be significantly related to adherence to ART treatment (p = 0.004). The findings of this study suggest that family support is a crucial factor in the adherence to ART treatment among HIV/AIDS patients.","PeriodicalId":20086,"journal":{"name":"Pharmacia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135268290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}